Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $10.8 million.

  • GeneDx Holdings' Cash from Financing Activities fell 22.91% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.9 million, marking a year-over-year decrease of 7.28%. This contributed to the annual value of $44.2 million for FY2024, which is 76.29% down from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Cash from Financing Activities is $10.8 million, which was up 3,012.14% from $346,000 recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Cash from Financing Activities ranged from a high of $499.4 million in Q3 2021 and a low of -$2.4 million during Q2 2021.
  • Its 3-year average for Cash from Financing Activities is $23.2 million, with a median of $10.8 million in 2025.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 83,011.25% in 2023, then crashed by 105.29% in 2024.
  • Over the past 5 years, GeneDx Holdings' Cash from Financing Activities (Quarterly) stood at -$1.0 million in 2021, then soared by 106.32% to $65,000 in 2022, then skyrocketed by 72,366.15% to $47.1 million in 2023, then plummeted by 34.14% to $31.0 million in 2024, then declined by 22.91% to $10.8 million in 2025.
  • Its Cash from Financing Activities was $10.8 million in Q3 2025, compared to $346,000 in Q2 2025 and $13.7 million in Q1 2025.